| Date | Title | Description | Source |
| 31.01.2022 | Immutep : to Present at February Investor Conferences | ASX/Media Release
Immutep to Present at February Investor Conferences
SYDNEY, AUSTRALIA - 31 Janua... | marketscre... |
| 07.01.2022 | Amylyx Pharmaceuticals Announces Pricing of Upsized Initial ... | Amylyx Pharmaceuticals, Inc. (“Amylyx”), a clinical-stage pharmaceutical company working on developi... | marketscre... |
| 03.01.2022 | Amylyx Pharmaceuticals Announces Launch of Initial Public Of... | Amylyx Pharmaceuticals, Inc. (“Amylyx”), a clinical-stage pharmaceutical company working on developi... | marketscre... |
| 11.11.2021 | 908 Devices Announces Pricing of Public Offering | 908 Devices Inc. (NASDAQ: MASS), a pioneer of purpose-built handheld and desktop mass spec devices f... | marketscre... |
| 11.11.2021 | Mirati Therapeutics Announces Pricing of Public Offering of ... | SAN DIEGO, Nov. 10, 2021 /PRNewswire/ -- Mirati Therapeutics, Inc. (Nasdaq: MRTX), a clinical-stage ... | marketscre... |
| 10.11.2021 | Mirati Therapeutics Announces Proposed Public Offering of Co... | SAN DIEGO, Nov. 9, 2021 /PRNewswire/ -- Mirati Therapeutics, Inc. (Nasdaq: MRTX) a clinical-stage on... | marketscre... |
| 09.11.2021 | 908 Devices Announces Launch of Public Offering | 908 Devices Inc. (NASDAQ: MASS), a pioneer of purpose-built handheld and desktop mass spec devices f... | marketscre... |
| 02.11.2021 | Compass Therapeutics Announces Pricing of Approximately $125... | Compass Therapeutics, Inc. (the “Company”), a clinical-stage biopharmaceutical company developing pr... | marketscre... |
| 01.11.2021 | Compass Therapeutics Announces Proposed Public Offering of C... | Compass Therapeutics, Inc. (the “Company”), a clinical stage biopharmaceutical company developing pr... | marketscre... |
| 29.10.2021 | Aura Biosciences Announces Pricing of Initial Public Offerin... | Aura Biosciences, Inc. (“Aura”), a clinical-stage oncology company developing a novel class of virus... | marketscre... |
| 22.10.2021 | Minerva Surgical : Announces Pricing of Initial Public Offer... | SANTA CLARA, Calif., Oct. 21, 2021 /PRNewswire/ -- Minerva Surgical, Inc. (Minerva Surgical), a wome... | marketscre... |
| 18.10.2021 | Bicycle Therapeutics : Announces Closing of Public Offering ... | Bicycle Therapeutics plc (Nasdaq: BCYC), a biotechnology company pioneering a new and differentiated... | marketscre... |
| 13.10.2021 | Bicycle Therapeutics : Announces Pricing of Upsized Public O... | Bicycle Therapeutics plc (Nasdaq: BCYC), a biotechnology company pioneering a new and differentiated... | marketscre... |
| 12.10.2021 | IsoPlexis : Announces Closing of Public Offering | BRANFORD, Conn., Oct. 12, 2021 /PRNewswire/ -- IsoPlexis Corporation ("IsoPlexis"), a lead... | marketscre... |
| 08.10.2021 | IsoPlexis : Announces Pricing of Initial Public Offering | BRANFORD, Conn., Oct. 7, 2021 /PRNewswire/ -- IsoPlexis Corporation ("IsoPlexis"), a leade... | marketscre... |
| 07.10.2021 | Theseus Pharmaceuticals : Announces Pricing of Initial Publi... | CAMBRIDGE, Mass., Oct. 6, 2021 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. ("Theseus"), ... | marketscre... |
| 23.09.2021 | Synlogic : Announces Pricing of Public Offering of Common St... | CAMBRIDGE, Mass., Sept. 22, 2021 /PRNewswire/ -- Synlogic (Nasdaq: SYBX) a clinical stage company br... | marketscre... |
| 22.09.2021 | Synlogic : Announces Proposed Public Offering of Common Stoc... | CAMBRIDGE, Mass., Sept. 22, 2021 /PRNewswire/ -- Synlogic (Nasdaq: SYBX), a clinical stage company b... | marketscre... |
| 09.08.2021 | Roger Salazar, Jr. Joins SVB Leerink As Managing Director An... | SVB Leerink, a leading investment bank specializing in healthcare and life sciences, announced that ... | aithority.... |
| 04.08.2021 | Avidity Biosciences, Inc. : Announces Pricing of Public Offe... | LA JOLLA, Calif., Aug. 3, 2021 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmac... | marketscre... |
| 02.08.2021 | Avidity Biosciences, Inc. : Announces Proposed Public Offeri... | LA JOLLA, Calif., Aug. 2, 2021 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmac... | marketscre... |
| 27.07.2021 | Caribou Biosciences : Announces Closing of Upsized Initial P... | Caribou Biosciences, Inc., (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmac... | marketscre... |
| 23.07.2021 | Caribou Biosciences : Announces Pricing of Upsized Initial P... | Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome-editing biopharmaceutical company,... | marketscre... |
| 22.07.2021 | Natera : Announces Pricing of Follow-On Offering | AUSTIN, Texas, July 21, 2021 /PRNewswire/ -- Natera, Inc. (Nasdaq: NTRA), a pioneer and global leade... | marketscre... |
| 21.07.2021 | Natera : Launches Proposed Follow-On Offering | AUSTIN, Texas, July 20, 2021 /PRNewswire/ -- Natera, Inc. (Nasdaq: NTRA) ("Natera"), a pio... | marketscre... |
| 01.07.2021 | Graphite Bio : Announces Closing of Upsized Initial Public O... | Graphite Bio, Inc. (Nasdaq: GRPH), a clinical-stage, next-generation gene editing company focused on... | marketscre... |
| 25.06.2021 | Elevation Oncology : Announces Pricing of Initial Public Off... | NEW YORK, June 24, 2021 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), a clinical stage bi... | marketscre... |
| 25.06.2021 | Theravance Biopharma, Inc. : Announces Pricing of Public Off... | DUBLIN, June 24, 2021 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Bi... | marketscre... |
| 25.06.2021 | Graphite Bio Announces Pricing of Upsized Initial Public Off... | Graphite Bio, Inc., a clinical-stage, next-generation gene editing company focused on therapies that... | marketscre... |
| 24.06.2021 | Theravance Biopharma, Inc. : Announces Proposed Public Offer... | DUBLIN, June 24, 2021 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Bi... | marketscre... |
| 22.06.2021 | Ben Brown Joins SVB Leerink as Senior Managing Director to F... |
BOSTON, June 22, 2021 /PRNewswire/ -- SVB Leerink, a leading investment bank specializing in healt... | prnewswire... |
| 20.05.2021 | SVB Leerink Hires Anurag Jindal to Expand Biopharma Investme... |
BOSTON, May 20, 2021 /PRNewswire/ -- SVB Leerink, a leading investment bank specializing in health... | prnewswire... |
| 14.05.2021 | AXONICS, INC.
Axonics : reg; Announces Closing of Public St... | Axonics, Inc. (Nasdaq: AXNX), (“Axonics”), a global medical technology company that is developing an... | marketscre... |
| 13.05.2021 | INSMED INCORPORATED
Insmed Incorporated : Announces Closing... | BRIDGEWATER, N.J., May 13, 2021 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM) announced today t... | marketscre... |
| 12.05.2021 | AXONICS, INC.
Axonics : reg; Announces Upsize and Pricing o... | Axonics, Inc. (Nasdaq: AXNX) (“Axonics”), a global medical technology company that has developed and... | marketscre... |
| 11.05.2021 | INSMED INCORPORATED
Insmed Incorporated : Announces Pricing... | BRIDGEWATER, N.J., May 11, 2021 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM) announced today t... | marketscre... |
| 11.05.2021 | AXONICS, INC.
Axonics : reg; Announces Proposed Public Offe... | Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commerciali... | marketscre... |
| 29.04.2021 | ALDEYRA THERAPEUTICS, INC.
Aldeyra Therapeutics, Inc. : Ann... | Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused ... | marketscre... |
| 27.04.2021 | ALDEYRA THERAPEUTICS, INC.
Aldeyra Therapeutics, Inc. : Ann... | Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused ... | marketscre... |
| 22.04.2021 | Mission Therapeutics takes part in SVB Leerink Biopharma Pri... | Mission Therapeutics, a drug discovery and development company focused on selectively inhibiting deu... | cambridgen... |
| 22.04.2021 | Mission Therapeutics takes part in SVB Leerink Biopharma Pri... | Mission Therapeutics takes part in SVB Leerink Biopharma Private Company Connect event
22-04-2021
... | cambridgen... |
| 16.04.2021 | SYNLOGIC, INC.
Synlogic : Announces Pricing of Public Offer... | CAMBRIDGE, Mass., April 16, 2021 /PRNewswire/ -- Synlogic (Nasdaq: SYBX) a clinical stage company br... | marketscre... |
| 15.04.2021 | SYNLOGIC, INC.
Synlogic : Announces Proposed Public Offerin... | CAMBRIDGE, Mass., April 15, 2021 /PRNewswire/ -- Synlogic (Nasdaq: SYBX), a clinical stage company b... | marketscre... |
| 06.04.2021 | SVB Leerink Builds out Structured Finance Practice |
BOSTON, April 6, 2021 /PRNewswire/ -- SVB Leerink, a leading investment bank specializing in healt... | prnewswire... |
| 30.03.2021 | EDGEWISE THERAPEUTICS, INC.
Edgewise Therapeutics : Announc... | Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on d... | marketscre... |
| 26.03.2021 | Edgewise Therapeutics : Announces Pricing of Initial Public ... | Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on de... | marketscre... |
| 26.03.2021 | AVEO PHARMACEUTICALS, INC.
AVEO Pharmaceuticals : Announces... | AVEO Oncology (Nasdaq: AVEO) today announced the closing of its previously announced underwritten pu... | marketscre... |
| 22.03.2021 | AVEO Announces Proposed Public Offering of Common Stock | BOSTON--(BUSINESS WIRE)--Mar 22, 2021--
AVEO Oncology (Nasdaq: AVEO) today announced that it has co... | oaoa.com/n... |
| 01.03.2021 | Adamas Pharmaceuticals Announces Closing of Public Offering ... | EMERYVILLE, Calif.--(BUSINESS WIRE)--Mar 1, 2021--
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a c... | oaoa.com/n... |
| 24.02.2021 | Adamas Pharmaceuticals Announces Launch of Follow-on Public ... | EMERYVILLE, Calif.--(BUSINESS WIRE)--Feb 24, 2021--
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a ... | oaoa.com/n... |
| 10.08.2020 | Immunic, Inc. Announces Closing of $103.5 Million Public Off... | NEW YORK, August 10, 2020 – Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company... | bmp.com/de... |
| 12.12.2019 | Aurinia Closes $191.7M Public Offering of Common Shares | VICTORIA, British Columbia–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“A... | lumiravent... |
| 09.12.2019 | Aurinia Prices US$166.7M Public Offering of Common Shares | VICTORIA, British Columbia–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“A... | lumiravent... |
| 29.10.2019 | CENTOGENE Announces Proposed Initial Public Offering of Comm... | October 28, 2019 at 8:53 AM EDT
CAMBRIDGE, Mass. and ROSTOCK, Germany, Oct. 28, 2019 (GLOBE NEWSWIR... | tvm-lifesc... |
| 17.09.2019 | Satsuma Pharmaceuticals Completes $90.8M Initial Public Offe... | SOUTH SAN FRANCISCO, Calif. — Satsuma Pharmaceuticals, Inc. (“Satsuma” or the “Company”) (Nasdaq: ST... | lumiravent... |
| 03.09.2019 | Satsuma Pharmaceuticals Inc. Proposes Initial Public Offerin... | SOUTH SAN FRANCISCO, Calif., Sept. 3, 2019 /PRNewswire/ — Satsuma Pharmaceuticals, Inc. (“Satsuma”),... | lumiravent... |
| - | Castle Biosciences Announces Pricing of Initial Public Offer... | FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. announced today the pricing of its ini... | acsbrighte... |
| - | Here's a rundown of 23 top healthcare banker moves as firms ... | Samantha Lee/Insider This story is available exclusively to Insider subscribers. Become an Insider a... | businessin... |
| - | AVEO Announces Pricing of $48.0 Million Public Offering of C... | BOSTON--(BUSINESS WIRE)--Mar 23, 2021--
AVEO Oncology (Nasdaq: AVEO) today announced that it has pr... | oaoa.com/n... |
| - | Adamas Pharmaceuticals Announces Pricing of Follow-on Public... | EMERYVILLE, Calif.--(BUSINESS WIRE)--Feb 24, 2021--
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a ... | oaoa.com/n... |